Teva Pharmaceutical Industries Limited Receives Tentative Approval For Generic Protonix(R) Delayed Release Tablets, 20 mg and 40 mg
JERUSALEM--(BUSINESS WIRE)--April 21, 2006--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA - News) announced today that the U.S. Food and Drug Administration has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Wyeth's Protonix® (Pantoprazole Sodium) Delayed Release (DR) Tablets, 20 mg and 40 mg.